UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Three‐dimensional cardiac computed tomography compared with autopsied material for the assessment of the mitral valve

Clinical anatomy (New York, N.Y.), 2023-03, Vol.36 (2), p.250-255

2023

Volltextzugriff (PDF)

Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk

Medicina (Kaunas, Lithuania), 2024-07, Vol.60 (7), p.1124

2024

Volltextzugriff (PDF)

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels

Archives of medical science, 2024-01, Vol.20 (1), p.8-27

2024

Volltextzugriff (PDF)

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund

Postępy w kardiologii interwencyjnej, 2022-06, Vol.18 (2), p.162-166

2022

Volltextzugriff (PDF)

Anatomic Variations of Renal Arteries as an Important Factor in the Effectiveness of Renal Denervation in Resistant Hypertension

Journal of cardiovascular development and disease, 2023-08, Vol.10 (9), p.371

2023

Volltextzugriff (PDF)

Redo of sympathetic renal denervation in a patient with resistant hypertension and anatomical variation of renal arteries

Postępy w kardiologii interwencyjnej, 2023-06, Vol.19 (2), p.190-191

2023

Volltextzugriff (PDF)

Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension

Postępy w kardiologii interwencyjnej, 2021-01, Vol.17 (2), p.239-241

2021

Volltextzugriff (PDF)

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)

Cardiovascular ultrasound, 2017-09, Vol.15 (1), p.24-24, Article 24

2017

Volltextzugriff (PDF)

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy

Postępy w kardiologii interwencyjnej, 2020-01, Vol.16 (1), p.97-101

2020

Volltextzugriff (PDF)

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

Polskie archiwum medycyny wewne̦trznej, 2017-06, Vol.126 (6), p.445-447

2017

Volltextzugriff (PDF)

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes

Kardiologia polska, 2019-01, Vol.77 (4), p.475-477

2019

Volltextzugriff (PDF)

Pharmacotherapy of Aortic Stenosis-Success or Failure?

Current pharmaceutical biotechnology, 2012-10, Vol.13 (13), p.2497-2502

2012

Volltextzugriff (PDF)

Pharmacotherapy of aortic stenosis-success or failure?

Current pharmaceutical biotechnology, 2012-10, Vol.13 (13), p.2497-2502

2012

Volltextzugriff (PDF)

The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy

Postępy w kardiologii interwencyjnej, 2017, Vol.13 (2), p.178-179

2017

Volltextzugriff (PDF)

Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy

Postępy w kardiologii interwencyjnej, 2016, Vol.12 (4), p.380-382

2016

Volltextzugriff (PDF)

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function - advanced diagnosis and therapy in heart failure

Postępy w kardiologii interwencyjnej, 2017, Vol.13 (2), p.173-175

2017

Volltextzugriff (PDF)

Release of troponin after exercise stress test in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2020-09, Vol.106 (18), p.1447-1447

2020

Volltextzugriff (PDF)

Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study

Journal of the American College of Cardiology, 2020-03, Vol.75 (10), p.1242-1242

2020

Volltextzugriff (PDF)

Letter by Rajtar-Salwa and Dimitrow Regarding Article, “Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart”

Circulation (New York, N.Y.), 2018-07, Vol.138 (3), p.331-332

2018

Volltextzugriff (PDF)

Exercise stress test methodology and safety in hypertrophic cardiomyopathy

European journal of preventive cardiology, 2020-11, Vol.27 (17), p.1819-1820

2020

Volltextzugriff (PDF)

Autosomal recessive hypercholesterolemia: the first experience in Poland

Polskie archiwum medycyny wewne̦trznej, 2023-06, Vol.133 (6)

2023

Volltextzugriff (PDF)

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

BioMed research international, 2016-01, Vol.2016 (2016), p.1-8

2016

Volltextzugriff (PDF)

Genetically confirmed transthyretin amyloidosis primarily referred as hypertrophic cardiomyopathy

Polskie archiwum medycyny wewne̦trznej, 2021-12

2021

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(77)

Sprache

Englisch
(69)
Polnisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Three‐dimensional cardiac computed tomography compared with autopsied material for the assessment of the mitral valve

Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk

Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels

Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund

Anatomic Variations of Renal Arteries as an Important Factor in the Effectiveness of Renal Denervation in Resistant Hypertension

Redo of sympathetic renal denervation in a patient with resistant hypertension and anatomical variation of renal arteries

Long-term benefit of redo sympathetic renal denervation in a patient with resistant hypertension

Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014)

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy

Associaton of elevated troponin levels with increased heart rate and higher frequency of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy

Prevalence of familial hypercholesterolemia in patients with acute coronary syndromes

Pharmacotherapy of Aortic Stenosis-Success or Failure?

Pharmacotherapy of aortic stenosis-success or failure?

The diagnostic role of cardiac magnetic resonance used "first and last time in life" in a patient with a suspected dilated phase of hypertrophic cardiomyopathy

Role of cardiac magnetic resonance in differentiating between acute coronary syndrome and apical hypertrophic cardiomyopathy

Positron emission tomography for myocardial viability assessment before myocardial revascularization in a patient with extremely impaired left ventricular systolic function - advanced diagnosis and therapy in heart failure

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry

Release of troponin after exercise stress test in hypertrophic cardiomyopathy

Reversed Septal Curvature Predicts Sudden Death in Hypertrophic Cardiomyopathy in Earlier Study

Letter by Rajtar-Salwa and Dimitrow Regarding Article, “Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart”

Exercise stress test methodology and safety in hypertrophic cardiomyopathy

Autosomal recessive hypercholesterolemia: the first experience in Poland

Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment

Genetically confirmed transthyretin amyloidosis primarily referred as hypertrophic cardiomyopathy

Suchergebnisse filtern